Application of Artificial Intelligence in Radiation Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 20 June 2025 | Viewed by 111
Special Issue Editors
Interests: image-guided intervention; multimodality medical imaging; machine learning
Interests: radiation therapy; segmentation; deep learning
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Radiation oncology has long been at the forefront of technological innovation in cancer treatment. The advent of artificial intelligence (AI) marks a pivotal advancement, gaining consensus as the fourth industrial revolution. This Special Issue focuses on the integration of AI in radiation oncology, medical physics, and cancer biology, highlighting the substantial research and innovations that have emerged.
We invite submissions that explore the application of AI in various areas, including but not limited to the following:
- Improving medical imaging and diagnostics;
- Target and organ segmentation;
- Treatment planning and optimization;
- Adaptive radiation therapy;
- Predictive modeling of treatment outcomes;
- Enhancing patient safety and quality assurance;
- Automating clinical workflows;
- Personalizing cancer treatment;
- Identifying biomarkers for treatment response.
Contributions that address ethical considerations and other related topics on AI in radiation oncology are also welcome.
Dr. Xiaofeng Yang
Dr. Lei Qiu
Dr. Tonghe Wang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- radiation oncology
- medical physics
- cancer biology
- medical imaging
- segmentation
- treatment planning
- adaptive radiation therapy
- predictive modeling
- patient safety
- clinical workflows
- personalized treatment
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
